Manufacturers Face Challenges and Regulatory Changes

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-11-02-2001, Volume 25, Issue 11

Threats of bioterrorism generate new reulatory policies to protect the public against biological warfare.

Related Content:

Regulatory WatchPharmaceutical Technology-11-02-2001
Signing Off from Washington
Industry Challenges Medicare Price Negotiation Scheme
Drug Shortages Continue to Plague FDA and Manufacturers